Aberrant expression of the polarity complex atypical PKC and non-muscle myosin IIA in active and inactive inflammatory bowel disease.
Virchows Arch., Sep;459(3):331-8 (2011)
Genetics in diagnosing and managing inflammatory bowel disease.
Gastroenterol. Clin. North Am., Jun;41(2):513-22 (2012)
Cancer in inflammatory bowel disease: lessons from animal models.
Curr. Opin. Gastroenterol., Jul;28(4):327-33 (2012)
Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Semin. Immunol., Aug;21(4):242-53 (2009)
Pathogen recognition receptors, cancer and inflammation in the gut.
Curr Opin Pharmacol., Dec;9(6):680-7 (2009)
Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.
Nat. Rev. Immunol., Feb;10(2):131-44 (2010)
Innate immunity in the small intestine.
Curr. Opin. Gastroenterol., Mar;27(2):125-31 (2011)
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Inflamm. Bowel Dis., Jun;15(6):829-36 (2009)
Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.
Inflamm. Bowel Dis., Jul;15(7):997-1006 (2009)
Practical techniques for detection of Toll-like receptor-4 in the human intestine.
Methods Mol. Biol., 517:345-61 (2009)
Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.
Innate Immun., Apr;16(2):93-103 (2010)
Lipopolysaccharide potentiates polychlorinated biphenyl-induced disruption of the blood-brain barrier via TLR4/IRF-3 signaling.
Toxicology., Aug (2012)
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.
Am. J. Gastroenterol., Apr;106(4):741-7 (2011)
Biological markers in inflammatory bowel disease: practical consideration for clinicians.
Gastroenterol. Clin. Biol., Jun;33 Suppl 3:S158-73 (2009)
NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression.
Aliment. Pharmacol. Ther., Jul;30(1):71-81 (2009)
Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naÃ¯ve patients.
Aliment. Pharmacol. Ther., Feb;29(3):273-8 (2009)
Role of Toll-like receptors in gastrointestinal malignancies.
Oncogene., Jan;27(2):234-43 (2008)
TLR4 signalling in the intestine in health and disease.
Biochem. Soc. Trans., Dec;35(Pt 6):1473-8 (2007)
Crohn's ileitis after liver transplantation from a living related donor with Crohn's disease.
Gut., Sep;53(9):1389-90 (2004)
Infliximab in the treatment of medically refractory indeterminate colitis.
Aliment. Pharmacol. Ther., Oct;18(7):741-7 (2003)